By representing equities in multi sectors we offset investor risk no different than the approach we would take in our own investment portfolios. Brisco acts on a referral basis, all clients are scrutinized through layers of due diligence by capital market members in order to protect the investment community we represent. The system is not perfect by any means but every precaution is needed to avoid investment losses in today’s volatile market.
Trenchant Capital is an investment issuer that has formed a strategic alliance with one of the largest private equity firms in Canada. read more…
Immunovaccine is a clinical-stage vaccine development company focused on advancing its patented DepoVax™ vaccine adjuvanting platform and product candidates for cancer therapy and infectious diseases.